Brought to you by 
Besins International licenses Testogel to Schering
01 Aug 2003
Executive Summary
Schering AG has licensed exclusive European rights (covering most countries in this territory) to Laboratoires Besins International's (private French pharmaceutical company--mostly women's health products) Testogel (testosterone) topical male hormone replacement drug.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Besins International licenses Testogel to Schering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice